reference/16769273

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16769273

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, P.H.S.
endingPage	928
issn	1099-1557 1053-8569
issueIdentifier	9
pageRange	920-928
publicationName	Pharmacoepidemiology and Drug Safety
startingPage	920
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
bibliographicCitation	Brouwer ES, West SL, Kluckman M, Wallace D, Masica AL, Ewen E, Kudyakov R, Cheng D, Bowen J, Fleming NS. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record. Pharmacoepidemiol Drug Saf. 2012 Sep;21(9):920–8. doi: 10.1002/pds.2262. PMID: 22250059.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fcd1f628a0c59b077b74bb3f254e707 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d90e846772ee40c31d8be1fa145716a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4838-8182 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a272569a98ac43a066ecf017ab0893b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b5128543abe1ae9ea9d9d97edb7c7d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_004a3fcdb921911e234643ef3bbca16e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad413e2cb5bd78855c4dcfae40402957 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09abe0f15ae16335ad4f1444a4eed550 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1706f2cb52b65d594d37c99c0c51ce3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96e2ab7f20d37ae58cbdd7caad9feb38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26bb01eee5e6cdbbe0eb0624ca5559a9
date	2012-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/pds.2262 https://pubmed.ncbi.nlm.nih.gov/22250059
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22236 https://portal.issn.org/resource/ISSN/1099-1557 https://portal.issn.org/resource/ISSN/1053-8569
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor‐based electronic health record
discusses	http://id.nlm.nih.gov/mesh/M0010903
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D010818Q000706 http://id.nlm.nih.gov/mesh/D003924Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D057286Q000706 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D016208 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D044469 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D012044 http://id.nlm.nih.gov/mesh/D011320 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D016015
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1fa591128e20aed5298081f96090e2b3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3fe1944ff40134a85813108aead7ab15 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71567 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104818 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ac5585d98646d255299c359140537783 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5437

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128635168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136164596 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129712660

Total number of triples: 66.